CV Sciences (OTC: CANV) focuses on drug development activities on products containing the hemp plant extract cannabidiol (CBD) as the active pharmaceutical ingredient, and also is engaged in the sale of CBD, and the development, marketing and sale of end consumer products containing CBD, which is refined into its own PlusCBD Oil™ brand. CV Sciences operates two distinct divisions: pharmaceuticals and consumer products. These divisions are supported by its medical and scientific advisory board, and state‐of‐the art production facilities. The company has achieved promising preclinical results in the development of cannabinoid medicines for treatment of a range of medical conditions. For more information, visit the company’s website at www.cvsciences.com